Published • loading... • Updated
Long Qt Syndrome and Risk of Cardiac Arrest, an Innovative Therapy From Italy
Summary by Giornale Radio
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
(Adnkronos) • A therapy already used in a genetic disease, cystic fibrosis, could offer a new perspective also for some patients with long type 2 Qt syndrome (Lqt2), a hereditary heart disease associated with the risk of cardiac arrest. This is what emerges from the results of the Mast2 study, a phase clinical trial [...]
notizie.it+2 Reposted by 2 other sources
(Adnkronos) - A therapy already used in a genetic disease, cystic fibrosis, could offer a new perspective also for some affected patients
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
